EXAS logo

EXAS
Exact Sciences Corp.

11,301
Mkt Cap
$19.31B
Volume
2.61M
52W High
$102.66
52W Low
$38.81
PE Ratio
-19.11
EXAS Fundamentals
Price
$101.63
Prev Close
$101.65
Open
$101.66
50D MA
$89.26
Beta
0.91
Avg. Volume
4.57M
EPS (Annual)
-$5.59
P/B
7.70
Rev/Employee
$394,123.86
Loading...
Loading...
News
all
press releases
Select Medical Expands Rehab Footprint Through Vibra Healthcare JV
SEM teams up with Vibra Healthcare to run a 76-bed rehab hospital in Southern Kentucky, expanding its post-acute care footprint through a capital-efficient JV.
Zacks·18h ago
News Placeholder
More News
News Placeholder
ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies
Alumis shares jump 95% after envudeucitinib meets all endpoints in two phase III plaque psoriasis studies, showing strong skin clearance.
Zacks·18h ago
News Placeholder
JNJ's Nipocalimab Meets Goal in Phase II Study for Systemic Lupus
J&J's phase IIb JASMINE study on nipocalimab meets key endpoints in systemic lupus erythematosus, supporting plans to advance the drug into phase III.
Zacks·18h ago
News Placeholder
ZBIO Tanks Despite Positive Data From Rare Autoimmune Diseases Study
Zenas BioPharma tanks nearly 52% despite positive INDIGO study data where obexelimab cut IgG4-RD flare risk by 56% and met all key endpoints.
Zacks·2d ago
News Placeholder
Halper Sadeh LLC Encourages EXAS, SOAR, BTBD Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages EXAS, SOAR, BTBD Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages EXAS, SOAR, BTBD Shareholders to Contact the Firm to Discuss Their...
PR Newswire·2d ago
News Placeholder
Exact Sciences (NASDAQ:EXAS) Upgraded by Zacks Research to "Strong-Buy" Rating
Zacks Research raised Exact Sciences from a "hold" rating to a "strong-buy" rating in a research report on Thursday...
MarketBeat·5d ago
News Placeholder
Cwm LLC Purchases 28,975 Shares of Exact Sciences Corporation $EXAS
Cwm LLC raised its position in Exact Sciences Corporation (NASDAQ:EXAS - Free Report) by 69.0% during the third quarter, according to its most recent filing with the SEC. The firm owned 70,953 shares...
MarketBeat·6d ago
News Placeholder
19,260 Shares in Exact Sciences Corporation $EXAS Purchased by Strait & Sound Wealth Management LLC
Strait & Sound Wealth Management LLC acquired a new stake in shares of Exact Sciences Corporation (NASDAQ:EXAS - Free Report) in the third quarter, according to its most recent disclosure with the...
MarketBeat·7d ago
News Placeholder
Smart Oncology: 5 Stocks Chasing the $317B Prize
Smart Oncology: 5 Stocks Chasing the $317B Prize Smart Oncology: 5 Stocks Chasing the $317B Prize PR Newswire VANCOUVER, BC, Dec. 31, 2025 Issued on behalf of Oncolytics Biotech Inc...
PR Newswire·8d ago
News Placeholder
How Tempus AI Is Building Scale While Near-Term Risks Persist
TEM is scaling via growing multi-quarter bookings, but delayed revenue conversion, MRD competition and rising losses keep near-term risks in focus.
Zacks·9d ago
<
1
2
...
>

Latest EXAS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.